Toviaz Approval History 
- FDA approved: Yes (First approved October 31st, 2008)
- Brand name: Toviaz
- Generic name: fesoterodine fumarate
- Company: Pfizer Inc.
- Treatment for: Overactive Bladder
Toviaz (fesoterodine fumarate) is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
FDA Approval History for Toviaz
| Date | Article |
|---|---|
| Oct 31, 2008 |  Pfizer's Toviaz (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder |
See also...
Toviaz (fesoterodine fumarate) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
